A comparison survey of GATA-3, ROR?t and FOXp3 genes expression levels in peripheral blood cells of rhinitis patients, before and after treatment with fexofenadine and fluticasone propionate.

Vice Chancellor for Research and Technology, Kermanshah University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新: 2018年2月22日

试验速览

暂无简介。

•1- People enter to the study should be at the age of 18 to 60 years, 2- They have to study and signature the testimonial before entrance to the study, 3- lack of abnormality in nasal anatomy, 4- having rhinitis symptoms which is confirmed by specialist physician, 5- not being suffered from: asthma, infectious disease, underlying diseases such as diabetes and chronic inflammatory diseases, 6- In addition, pregnant women, people above 65 and those people who suffer from rhinitis because of Senility will not enter the study.
•Exclusion criteria: 1- People suffering from infectious diseases or common cold during the period of study, 2- patients taking drugs other than drugs that must consume according to the research plan, during Performance of the project, 3- patients who have a fungal, viral or bacterial disease during the t curse of study, 4- patients who do not follow the recommended instructions. All these people will be excluded from the study.

发起方

Vice Chancellor for Research and Technology, Kermanshah University of Medical Sciences